Literature DB >> 1402824

Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection.

P Bouffard1, J P Lamelin, F Zoulim, D Lepot, C Trepo.   

Abstract

Peripheral blood mononuclear cells (PBMC) from 25 patients with chronic hepatitis B were tested for the presence of free monomeric hepatitis B virus (HBV) DNA migrating as a single 3.2 Kb band by Southern blot analysis. The PBMC were cultured for 7 days in the presence of phytohemagglutinin (PHA) or concanavalin A (ConA) both of which yielded a proliferative response. By contrast, both bacterial lipopolysaccharide (LPS) and interleukin 2 (IL2) failed to do so. Dot blot assays were used to monitor HBV DNA level increase within PBMC. Following mitogen exposure HBV DNA levels increased above pre-stimulation levels in 19/25 PHA cultures, 6/15 ConA cultures, 1/15 LPS cultures, and 1/15 IL2 cultures. In 15 patients, Southern blot analysis was carried out before and after PHA exposure. In 13/15 cases, a single 3.2 Kb band was observed in unstimulated cultures as well as in PHA cultures even though PHA induced a HBV DNA increase. One case exhibited bands migrating faster than the 3.2 Kb signal, compatible with replicating intermediates and one case provided evidence of viral concatemers within PBMC after PHA stimulation. No HBV DNA was detected in the culture supernatants. The increase of HBV DNA level in PBMC induced by mitogen was strongly associated with an increase in HBV DNA expression (HBV RNA and HBs antigen). These studies indicate that HBV DNA present in human PBMC does represent a potential reservoir for infection with endogenous reactivation following PBMC activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402824     DOI: 10.1002/jmv.1890370404

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

Review 3.  Clinical relevance of hepatitis B virus variants.

Authors:  Shan Gao; Zhong-Ping Duan; Carla S Coffin
Journal:  World J Hepatol       Date:  2015-05-18

4.  Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS.

Authors:  C Malavé Lara; M T Gorriño; C Campelo; P Lardelli; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

5.  Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.

Authors:  Z Lee; S Nishikawa; S Gao; J B Eksteen; M Czub; M J Gill; C Osiowy; F van der Meer; G van Marle; C S Coffin
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

6.  Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma.

Authors:  Kamyar Makvandi; Nastaran Ranjbari; Manoochehr Makvandi; Ali Ashraf Teimori; Niloofar Neisi; Mojtaba Rasti; Vida Alipour; Mostafa Albokord; Malek Kanani; Ramezan Ahadi; Ala Habibian
Journal:  Jundishapur J Microbiol       Date:  2015-11-21       Impact factor: 0.747

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.